Banks could miss out on $135 mln fees as Abbvie drops Shire deal
October 16, 2014 at 10:37 AM EDT
LONDON, Oct 16 (Reuters) - A decision by U.S. drugmaker AbbVie to scrap its plans to buy Dublin-based Shire could mean that bankers miss out on up to $135 million in fees linked to the deal.
